| Literature DB >> 21185721 |
Ping Ye1, Cyrille Kuhn, Miret Juan, Rahul Sharma, Brendan Connolly, Gordon Alton, Hu Liu, Robert Stanton, Natasha M Kablaoui.
Abstract
S6K1 (p70 S6 kinase-1) is thought to play a critical role in the development of obesity and insulin resistance, thus making it an attractive target in developing medicines for the treatment of these disorders. We describe a novel thiophene urea class of S6K inhibitors. The lead matter for the development of these inhibitors came from mining the literature for reports of weak off-target S6K activity. These optimized inhibitors exhibit good potency and excellent selectivity for S6K over a panel of 43 kinases. Copyright ÂEntities:
Mesh:
Substances:
Year: 2010 PMID: 21185721 DOI: 10.1016/j.bmcl.2010.11.069
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823